Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145145 | SCV000192193 | uncertain significance | Microcephaly 5, primary, autosomal recessive | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000726692 | SCV000279753 | uncertain significance | not provided | 2023-12-27 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Missense variant in a gene in which most reported pathogenic variants are truncating/loss of function; This variant is associated with the following publications: (PMID: 19770472, 12355089, 23611254) |
Illumina Laboratory Services, |
RCV000145145 | SCV000352689 | uncertain significance | Microcephaly 5, primary, autosomal recessive | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Eurofins Ntd Llc |
RCV000726692 | SCV000702127 | uncertain significance | not provided | 2018-06-11 | criteria provided, single submitter | clinical testing | |
Geisinger Autism and Developmental Medicine Institute, |
RCV000145145 | SCV000804444 | uncertain significance | Microcephaly 5, primary, autosomal recessive | 2017-06-28 | criteria provided, single submitter | provider interpretation | This 8 year old female with microcephaly (<2nd percentile) and intellectual disbality was found to carry a paternally inherited variant in the ASPM gene. The p.Arg1818Cys is present at 0.11% in the gnomAD dataset. Computational models predict the variant to be damaging. The patient also carries a maternally inherited ASPM variant (p.Leu2306SerfsX20), classified as a likely pathogenic. While homozygous or compound heterozygous variants in this gene are associated with autosomal recessive primary microcephaly, this patient also carries a maternally-inherited, pathogenic variant in KIF11, which is currently thought to be the underlying genetic etiology for her microcephaly and intellectual disability. |
Ce |
RCV000726692 | SCV001335215 | uncertain significance | not provided | 2020-02-01 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000145145 | SCV001529806 | uncertain significance | Microcephaly 5, primary, autosomal recessive | 2018-12-24 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV000726692 | SCV002295375 | uncertain significance | not provided | 2025-01-17 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1818 of the ASPM protein (p.Arg1818Cys). This variant is present in population databases (rs41299625, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with primary microcephaly (PMID: 23611254). ClinVar contains an entry for this variant (Variation ID: 157834). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ASPM protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV000145145 | SCV004178639 | uncertain significance | Microcephaly 5, primary, autosomal recessive | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000726692 | SCV005187124 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Centre de Biologie Pathologie Génétique, |
RCV001252168 | SCV001427918 | uncertain significance | Intellectual disability | 2019-01-01 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003905250 | SCV004719997 | likely benign | ASPM-related disorder | 2020-01-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |